Effect of 6-Azacytidine on the Course of Experimental Adenoviral Infection in Newborn Syrian Hamsters

References

• Bailey A, Mautner V. Phylogenic relationships among adenovirus serotypes. Virology 1994; 205 (2): 438–452.
   PubMed Web of Science ®Google Scholar
• Naesens L, Lenaerts L, Andrei G, et al. Antiadenovirus activities of several classes of nucleoside and nucleotide ana-logues. Antimicrob Agents Chemother 2005; 49 (3): 1010–1016.
   PubMed Web of Science ®Google Scholar
• La Rosa AM, Champlin RE, Mirza M, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001; 32 (6): 871–876.
   PubMed Web of Science ®Google Scholar
• Das A, Trousdale MD, Ren S, Lien EJ. Inhibition of her-pes simplex virus type 1 and adenovirus type 5 by heterocyclic Schiff bases of aminohydroxyguanidine tosylate. Antiviral Res 1999; 44 (3): 201–208.
   PubMed Web of Science ®Google Scholar
• De Clercq E, Sakuma T, Baba M, et al. Antiviral activity of phosphonylmethoxyalkyl derivatives of purines and pyrim-idines. Antiviral Res 1987; 8 (5-6): 261–272.
   PubMed Web of Science ®Google Scholar
• Arav-Boger R, Echavarria M, Forman M, Charache P, Persaud D. Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient. Pediatr Infect Dis J 2000; 19 (11): 1097–1100.
   PubMed Web of Science ®Google Scholar
• Shetty AK, Gans HA, So S, MilIan MT, Arvin AM, Gutierrez KM, Intravenous ribavirin therapy for adenovirus pneumonia. Pediatr Pulmonol 2000; 29 (1): 69–73.
   PubMed Web of Science ®Google Scholar
• Gavin PJ, Katz BZ. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 2002; 110 (1 pt 1): 1–8.
   PubMedGoogle Scholar
• Bordigoni P, Carret AS, Venard V, Witz F, Le Faou A. Treatment of adenovirus infections in patients undergoing allo-geneic hematopoietic stem cell transplantation. Clin Infect Dis 2001; 32 (9): 1290–1297.
   PubMedGoogle Scholar
• Trousdale MD, Goldschmidt PL, Nobrega R. Evaluation of Ganciclovir against human adenovirus type 5 infection in cell culture and cotton rat eyes. Antiviral Res 1993; 20 suppl. 1: 48.
   Google Scholar
• Chen FE, Liang RH, Lo JY, Yuen KY, Chan TK, Peiris M. Treatment of adenovirus-associated haemorrhagic cystitiswith ganciclovir. Bone Marrow Transplant 1997; 20 (11): 997–999.
   PubMed Web of Science ®Google Scholar
• Hillenkamp J, Reinhard T, Ross RS, et al. The effect of cidofovir 1% with and without cyclosporin A 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology 2002; 109 (5): 845–850.
   PubMed Web of Science ®Google Scholar
• Hoffman JA, Shah AJ, Ross LA, Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7 (7): 388–394.
   PubMed Web of Science ®Google Scholar
• Romanowski EG, Yates KA, Gordon YJ. Antiviral pro-phylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model. Antiviral Res 2001; 52 (3): 275–280.
   PubMed Web of Science ®Google Scholar
• Romanowski EG, Gordon YJ, Araullo-Cruz T, Yates KA, Kinchington PR. The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand white rabbit ocular model. Invest Ophthalmol Vis Sci 2001; 42 (8): 1812–1815.
   PubMed Web of Science ®Google Scholar
• Safrin S, Cherrington J, Jaffe HS. Cidofovir. Review of current and potential clinical uses. Adv Exp Med Biol 1999; 458: 111–120.
   PubMed Web of Science ®Google Scholar
• Hitchcock MJM, Jaffe HS, Martin JC, Stagg RJ. Cidofovir, a new agent with potent anti-herpesvirus activity. Antivir Chem Chemother 1996; 7 (3): 115–127.
   Web of Science ®Google Scholar
• Gordon YJ, Naesens L, De Clercq E, Maudgal PC, Veckeneer M. The treatment of adenoviral conjunctivitis with topical cidofovir. Cornea. 1996;15 (5): 546.
   PubMed Web of Science ®Google Scholar
• Coca S, Perazella MA. Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity. Am J Med Sci 2002; 324 (6): 342–344.
   PubMed Web of Science ®Google Scholar
• Gordon YJ, Araullo-Cruz TP, Johnson YP, Romanowski EG, Kinchington PR. Isolation of human aden-ovirus type 5 variants resistant to the antiviral Cidofovir. Invest Ophthalmol Vis Sci 1996; 37 (13): 2774–2778.
   PubMed Web of Science ®Google Scholar
• Kaneko H, Kato K, Mori S, Shigeta S. Antiviral activity of NMS03 against adenovirus in vitro. Antiviral Res 2001; 52 (3): 281–288.
   PubMed Web of Science ®Google Scholar
• Zarubaev VV, Slita AV, Krivitskaya VZ, Sirotkin AK, Kovalenko AL, Chatterjee NK. Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro. Antiviral Res 2003; 58 (2): 131–137.
   PubMed Web of Science ®Google Scholar
• Rautenschlein S, Miller RL, Sharma JM. The inhibitory effect of the imidazoquinolinamine S-28828 on the pathogen-esis of a type II adenovirus in turkeys. Antiviral Res 2000; 46 (3): 195–205.
   PubMed Web of Science ®Google Scholar
• Mentel R, Kinder M, Wegner U, Janta-Lipinski M, Matthes E. Inhibitory activity of 3-fluoro-2-deoxythymidine and related nucleoside analogues against adenoviruses in vitri. Antiviral Res 1997; 34 (3): 113–119.
   PubMed Web of Science ®Google Scholar
• Weber JM, Ruzindana-Umunyana A, Imbeault L, Sircar S. Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Res 2003; 58 (2): 167–173.
   PubMed Web of Science ®Google Scholar
• Alexeeva IV, Dyachenko NS, Nosach LN, et al. 6-Azacytidine —compound with wide spectrum of antiviral activi-ty. Nucleosides Nucleotides & Nucleic Acids 2001; 20 (4-7): 1147–1152.
   PubMed Web of Science ®Google Scholar
• Alexeeva IV, Palchikovskaya LI, Shalamay A, et al. N-4-Amino-acid derivatives of 6-azacytidine: structure-activity relationship. Acta Biochim Polon 2000; 47 (1): 95–101.
   PubMed Web of Science ®Google Scholar
• Vorbruggen H, Bennua B. Nucleoside synthesis. XXV. A new simple nucleoside synthesis. Chem. Ber 1981; 144: 1279–1286.
   Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxici-ty assays. J Immunol Methods 1983; 65 (1-2):55–63.
   PubMed Web of Science ®Google Scholar
• Puvion-Dutilleul F, Pudron J, Cajean-Feroldi C. Identification of intranuclear structures containing the 72K DNA-binding protein of human adenovirus type 5. Eur J Cell Biol 1984; 34 (2): 313–322.
   PubMed Web of Science ®Google Scholar
• Betts AO, Jennings AR, Zamont PH, Page Z. Inoculation of pigs with adenovirus of human origin. Nature 1962; 193 (4851): 45–46.
   PubMedGoogle Scholar
• Pereira HG, Allison AC, Niven JS. Fatal infection if newborn hamsters by an adenovirus of human origin. Nature 1962; 196: 244–245.
   Web of Science ®Google Scholar
• Hayder H, Blanden R, Korner H, Riminton DS, Sedgwick JD, Mallbacher A. Adenovirus-induced liver patholo-gy is mediated through TNF receptors I and II but is indepen-dent of TNF of lymphotoxin. J Immunol 1999; 163 (3): 1516–1520.
   PubMed Web of Science ®Google Scholar
• Gordon YJ, Romanowski E, Araullo-Cruz T. An ocular model of adenovirus type 5 infection in the NZ rabbit. Invest Ophthalmol Vis Sci. 1992; 33 (3): 574–580.
   PubMed Web of Science ®Google Scholar
• Galushko SV, Shishkina NP. Reversed-phase ion-paired high-performance liquid chromatographic determination of 6-azacytidine in blood. Chromatography 1985; 345 (1): 157–161.
   PubMed Web of Science ®Google Scholar
• Curran M, Noble S. Valganciclovir. Drugs 2001; 61 (8): 1145-1150.
   Google Scholar
• Hösel M, Schroer J, Webb D, Jaroshevskaja E, Doerfler W. Cellular and early viral factors in the interaction of adenovirus type 12 with hamster cells: the abortive response. Virus Res 2001; 81 (1-2):1–16.
   PubMed Web of Science ®Google Scholar